У нас вы можете посмотреть бесплатно FTS 15 - Day 2 - Renal Mass Ablation - What is the Sweet Spot? или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
FRS 15 - Day 2 - Renal Mass Ablation - What is the Sweet Spot? Dr. Tatiana Cabrera, an interventional radiologist, discusses the criteria for selecting renal lesions suitable for ablation. She emphasizes that while guidelines suggest ablation for small renal masses ( less than 3 cm), careful patient and lesion selection is crucial. Key Considerations: • Renal Nephrometry Score: A simple scoring system to assess tumor complexity, helpful for both surgeons and radiologists. • Ablate Score: A more radiologist-centric score considering factors like proximity to bowel and collecting system. • Patient Factors: Age, comorbidities, life expectancy, and previous treatments significantly influence treatment decisions. • Tumor Characteristics: Size, location, proximity to critical structures, and histological type are all important factors. The "Sweet Spot" for Ablation: Dr. Cabrera describes the ideal candidate for ablation as having a small, exophytic tumor located posteriorly and far from critical structures. However, she acknowledges that many real-world cases present with more complex scenarios. Challenges and Considerations: • Technical Challenges: Addressing challenges like tumor proximity to bowel or collecting system requires careful planning and techniques like fluid displacement. • Patient-Centered Approach: Involving patients in the decision-making process and considering their individual preferences is crucial. • Long-Term Management: Recognizing that renal cancer can be a chronic disease and planning for potential future treatments is essential. Overall: Dr. Cabrera emphasizes the importance of a multidisciplinary approach, considering patient factors, tumor characteristics, and technical feasibility when selecting renal lesions for ablation. She highlights the need for ongoing communication and collaboration between radiologists, urologists, and patients to optimize treatment outcomes.